Shoham, Israel

Tal Avziz

This inventor holds 1 USPTO granted patent. Top assignee: Simbionix Ltd.. Active years: 2026.


% Patents Active = 100.0

Average Co-Inventor Count = 4.0

ph-index = 1


Company Filing History:


Years Active: 2026

Loading Chart...
1 patent (USPTO):Explore Patents

Title: Tal Avziz: Innovator in Medical Simulation Technology

Introduction

Tal Avziz is a prominent inventor based in Shoham, Israel. He has made significant contributions to the field of medical simulation technology. His innovative approach has led to the development of a unique medical simulation system that enhances training and procedural accuracy.

Latest Patents

Tal Avziz holds a patent for a Multi-tool medical simulation system and method. This system comprises a casing device with at least one opening and features at least three selectable working stations. One of the working stations includes a router, while the operational tool consists of at least two packed tools capable of bursting out. The system is designed to simulate medical procedures by utilizing sensors and a controller that generates outputs based on the tools' positions within the casing device.

Career Highlights

Tal Avziz is associated with Simbionix Ltd., a company known for its advancements in medical simulation technology. His work at Simbionix has positioned him as a key player in the development of innovative training solutions for medical professionals.

Collaborations

Throughout his career, Tal has collaborated with notable colleagues, including Ariel Ben Moshe and Jacov Blank. These partnerships have contributed to the advancement of medical simulation technologies and have fostered a collaborative environment for innovation.

Conclusion

Tal Avziz's contributions to medical simulation technology exemplify the impact of innovation in healthcare. His patented system represents a significant advancement in training methodologies, ultimately improving medical procedures and patient outcomes.

Profile summary based on public USPTO records.
Please report any incorrect information to [email protected]
Loading…